Nakajima H, Golstein P, Henkart P A
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Exp Med. 1995 May 1;181(5):1905-9. doi: 10.1084/jem.181.5.1905.
The requirement for target cell nuclei in the two apoptotic death pathways used by cytotoxic lymphocytes was tested using model effector systems in which the granzyme and Fas pathways of target damage are isolated. Mast cell tumors expressing granzymes A and B in addition to cytolysin/perforin lysed tumor target cells about 10-fold more efficiently than comparable effector cells without granzymes. Enucleated cytoplast targets derived from these cells were also lysed with a similar 10-fold effect of granzymes. In contrast to cytoplasts, effector granzyme expression did not influence lysis of red cell targets. The Fas pathway was assessed using the selected cytotoxic T lymphocyte hybridoma subline d11S, which lysed target cells expressing Fas but not those lacking Fas. Similarly, cytoplasts derived from Fas+ but not Fas- cells were also readily lysed by these effector cells. Thus, neither the nucleus itself nor the characteristic apoptotic nuclear damage associated with the two major cell death pathways used by cytotoxic lymphocytes are required for cell death per se.
利用模型效应系统,在其中细胞毒性淋巴细胞所使用的两条凋亡死亡途径中,靶细胞核的需求得到了测试,在该模型效应系统中,靶细胞损伤的颗粒酶途径和Fas途径被分离出来。除了溶细胞素/穿孔素之外,还表达颗粒酶A和B的肥大细胞瘤裂解肿瘤靶细胞的效率比没有颗粒酶的可比效应细胞高约10倍。源自这些细胞的去核胞质体靶细胞也以类似的颗粒酶10倍效应被裂解。与胞质体相反,效应颗粒酶的表达不影响红细胞靶细胞的裂解。使用选定的细胞毒性T淋巴细胞杂交瘤亚系d11S评估Fas途径,该亚系裂解表达Fas的靶细胞,但不裂解缺乏Fas的靶细胞。同样,源自Fas+而非Fas-细胞的胞质体也很容易被这些效应细胞裂解。因此,细胞毒性淋巴细胞所使用的两条主要细胞死亡途径相关的细胞核本身或特征性凋亡核损伤,对于细胞死亡本身而言并非必需。